ALGN · NMS · Healthcare
Align Technology, Inc.
Also onShortfallConsensus DriftCrosscheck
Implied value per share
USD 90.32
Market price
USD 154.13
Implied upside
-41.4%
10-year forecast · Perpetuity growth terminal value · Mid-year discounting · Base case · Price 2026-11-02 · Accounts to 2025-12-31
Value Per Share
Same forecast, different terminal treatment. Percentages vs price.
Forecast Cashflows
Reporting currency (USD). Outflows negative.
| Line | FY26 | FY27 | FY28 | FY29 | FY30 | FY31 | FY32 | FY33 | FY34 | FY35 | CAGR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | USD 4.1bn | USD 4.3bn | USD 4.4bn | USD 4.5bn | USD 4.6bn | USD 4.8bn | USD 4.9bn | USD 5.0bn | USD 5.1bn | USD 5.3bn | +2.8% |
| EBIT | USD 678.8m | USD 699.5m | USD 720.3m | USD 741.2m | USD 762.2m | USD 783.4m | USD 804.6m | USD 825.8m | USD 847.0m | USD 868.1m | +2.8% |
| NOPAT | USD 536.3m | USD 552.6m | USD 569.0m | USD 585.6m | USD 602.2m | USD 618.9m | USD 635.6m | USD 652.3m | USD 669.1m | USD 685.8m | +2.8% |
| Add depreciation & amortisation | USD 170.9m | USD 176.1m | USD 181.3m | USD 186.6m | USD 191.9m | USD 197.2m | USD 202.5m | USD 207.8m | USD 213.2m | USD 218.5m | +2.8% |
| Less capital expenditure | USD -184.1m | USD -199.1m | USD -214.7m | USD -230.9m | USD -247.8m | USD -265.2m | USD -283.2m | USD -301.8m | USD -321.0m | USD -340.7m | +7.1% |
| Capex, % of revenue | 4.5% | 4.7% | 4.9% | 5.1% | 5.3% | 5.6% | 5.8% | 6.0% | 6.2% | 6.5% | - |
| Less increase in working capital | USD -25.8m | USD -35.9m | USD -36.2m | USD -36.4m | USD -36.6m | USD -36.7m | USD -36.8m | USD -36.9m | USD -36.9m | USD -36.8m | +4.0% |
| Free cashflow to firm | USD 497.2m | USD 493.6m | USD 499.4m | USD 504.8m | USD 509.7m | USD 514.1m | USD 518.1m | USD 521.5m | USD 524.5m | USD 526.8m | +0.6% |
| Discount factor | 0.9485 | 0.8533 | 0.7677 | 0.6906 | 0.6213 | 0.5589 | 0.5029 | 0.4524 | 0.4070 | 0.3661 | - |
| Present value | USD 471.6m | USD 421.2m | USD 383.4m | USD 348.6m | USD 316.7m | USD 287.4m | USD 260.5m | USD 235.9m | USD 213.4m | USD 192.9m | - |
| Present Value Of The Forecast | USD 3.1bn | ||||||||||
Discount Rate
Source shown per component. All overridable above.
| Risk-free rate | 4.89% | US 10-year Treasury (^TNX), 2026-11-02 |
| Equity risk premium | 4.23% | Damodaran, January 2026 |
| Beta | 1.494 | Reported 1.738, pulled toward 1.0 (Blume) |
| Cost of equity | 11.22% | Risk-free + beta x equity risk premium |
| Cost of debt | 6.89% | Assumed: risk-free + 200bp (interest expense not reported) |
| Market capitalisation | USD 10.9bn | 99.0% of capital |
| Total debt | USD 114.4m | 1.0% of capital, book value as a proxy |
| Tax rate | 21.0% | Effective, capped at statutory |
| WACC | 11.16% | E/V x Re + D/V x Rd x (1 - t) |
Terminal Value
Perpetuity growth is intrinsic. The exit multiple defaults to the company's current EV/EBITDA, so it answers a different question - what the shares are worth if today's rating holds and EBITDA grows as forecast.
Perpetuity growth at 2.50%
44% of EV
- Forecast FCFF, final year
- USD 526.8m
- Capex at depreciation, working capital in reinvestment
- USD 685.8m
- Less reinvestment at g/ROIC (17.8% of NOPAT)
- USD -122.2m
- Capitalised
- USD 563.6m
- ROIC (reported)
- 14.0%
- Terminal value, undiscounted
- USD 6.7bn
- Terminal value, discounted
- USD 2.4bn
- Enterprise value
- USD 5.6bn
- Less net debt
- USD -980.5m
- Equity value
- USD 6.6bn
Exit at 12.1x EBITDA
61% of EV
- Terminal value, undiscounted
- USD 13.2bn
- Terminal value, discounted
- USD 4.8bn
- Enterprise value
- USD 8.0bn
- Less net debt
- USD -980.5m
- Equity value
- USD 8.9bn
Spread between methods: 31%.
Sensitivity
Value per share (USD) by discount rate and long-run growth.
| Long-run growth | |||||
|---|---|---|---|---|---|
| Discount rate | 1.50% | 2.00% | 2.50% | 3.00% | 3.50% |
| 9.16% | 110.55 | 111.24 | 112.16 | 113.33 | 114.85 |
| 10.16% | 99.45 | 99.58 | 99.81 | 100.17 | 100.69 |
| 11.16% | 90.68 | 90.47 | 90.32 | 90.22 | 90.20 |
| 12.16% | 83.56 | 83.16 | 82.79 | 82.44 | 82.12 |
| 13.16% | 77.68 | 77.17 | 76.67 | 76.18 | 75.70 |
Outlined: this model. Green text: above today's price of 154.13. Shading: distance from this model's own value.
Priced In
What each input would have to be to justify the current price, one at a time.
| Input | Actual | Model | Implied | Gap |
|---|---|---|---|---|
| Revenue growth, a year | 2.6% | 2.7% | 11.9% | |
| EBIT margin | 17.5% | 16.5% | 29.5% | |
| Discount rate | - | 11.2% | 7.1% |
Live formulas, not pasted numbers - edit a driver and the workbook reprices.
Yahoo Finance and RBA data. General information, not advice. Methodology.